Business Details
49 Years
experience
Montana Cancer Consortium | Leading Cancer Research & Care
Founded in 1977, Montana Cancer Consortium has dedicated over four decades to advancing cancer care through clinical research in Montana, Idaho, and Wyoming. As an independent nonprofit organization, we collaborate with the National Cancer Institute to provide access to cutting-edge treatments and trials for rural populations. Our network of board-certified specialists delivers personalized care while focusing on treatment innovation, early diagnosis, prevention strategies, and symptom management.With over 120 active clinical trials and 5,000+ patients accrued historically, we remain committed to bridging healthcare gaps in underserved regions. Our mission prioritizes patient education, transparent decision-making, and improving outcomes through research-driven approaches.
Services
Clinical Trials
Cancer Treatment
Prevention Research
Symptom Management
Patient Accrual
Details
- Year established: 1977
Highlights and features
- 45+ years of experience in rural cancer research
- NCI-sponsored clinical trials unavailable elsewhere
- Board-certified specialists in three states
- 120+ active clinical trials for diverse cancers
- Focus on underserved rural populations
Associations and certifications
- National Cancer Institute (NCI)
Services
Clinical Trials
Our clinical trials evaluate new cancer treatments, diagnostic methods, and prevention strategies. Patients gain access to investigational therapies before widespread availability. Each trial follows strict protocols to ensure safety while advancing medical knowledge and improving patient outcomes.
Cancer Treatment
We provide advanced cancer treatment options through NCI-sponsored research programs. Our board-certified specialists deliver personalized care plans using the latest evidence-based approaches, including targeted therapies and precision medicine tailored to individual patient needs.
Prevention Research
Our prevention research focuses on identifying effective strategies to reduce cancer risk. Through clinical trials, we study lifestyle modifications, chemoprevention agents, and early detection methods to help individuals lower their cancer risk and improve population health outcomes.
Symptom Management
We develop and implement innovative approaches to managing cancer-related symptoms and treatment side effects. Our research focuses on improving quality of life through evidence-based interventions addressing pain, fatigue, and other common treatment challenges.
Patient Accrual
We facilitate patient enrollment in clinical trials through our network of 14 treatment sites. Our team helps patients navigate eligibility requirements, coordinate care, and access specialized research opportunities that match their specific cancer diagnosis and treatment needs.
Questions
What clinical trials are available through MCC?
We offer 120+ active NCI-sponsored clinical trials covering treatment, diagnosis, prevention, and symptom management for various cancers including breast, lung, leukemia, and rare malignancies.
How can I participate in a clinical trial?
Contact our Billings office to discuss eligibility. Our team will help match your diagnosis with available trials, explain protocols, and coordinate care with your local oncologist.
What states does MCC serve?
We serve patients in Montana, Idaho, and Wyoming through our network of 14 treatment locations across these three states.
Is MCC affiliated with the National Cancer Institute?
Yes, we receive funding through the NCI Community Oncology Research Program (NCORP) and conduct NCI-sponsored clinical trials.
What cancer types are studied in MCC trials?
Our trials cover brain, breast, gastrointestinal, genitourinary, gynecologic, head/neck, leukemia, lung, lymphoma, myeloma, sarcoma, skin, thoracic, and rare cancers.
How does MCC support rural cancer patients?
We bring clinical trial access to rural areas through our network of local oncologists, reducing travel needs while providing cutting-edge treatment options.
